+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Skin Allergy Therapeutics Market by Therapeutic Class, Treatment Type, Application Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030- Product Image
Skin Allergy Therapeutics Market by Therapeutic Class, Treatment Type, Application Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Skin Allergy Therapeutics Market by Therapeutic Class, Treatment Type, Application Type, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011762
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The skin allergy therapeutics market is experiencing robust transformation, with diverse therapeutic innovations and evolving patient care standards shaping opportunities for industry leaders and stakeholders. This report provides in-depth analysis and practical segmentation to inform investment, partnership, and operational strategies within this dynamic environment.

Market Snapshot: Skin Allergy Therapeutics

The global skin allergy therapeutics market grew from USD 5.43 billion in 2024 to USD 5.88 billion in 2025 and is projected to reach USD 8.74 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.25%. This expansion is influenced by increasing incidence rates, a broadening range of treatment modalities, and advances in biologics and digital solutions. Senior decision-makers should recognize the dynamic interplay between patient needs, regulatory forces, and innovation pipelines within this sector.

Scope & Segmentation

This report provides extensive segmentation to help organizations align strategies with fast-evolving therapeutic, technological, and regional developments:

  • Therapeutic Classes: Encompasses antihistamines (first- and second-generation), corticosteroids (high, medium, and low potency), and immune response modifiers including calcineurin and PDE-4 inhibitors.
  • Treatment Types: Details over-the-counter and prescription approaches, both systemic and topical, with implications for market volume and margins.
  • Application Forms: Covers creams, ointments (oil-in-water and water-in-oil base types), gels, lotions, and sprays addressing varied usage demands and patient adherence factors.
  • Distribution Channels: Assesses the role of hospital, online, and retail pharmacies including insights into private versus public institutions, branded versus third-party online platforms, and networked pharmacies versus independents.
  • End Users: Includes clinics (dermatology and general), homecare (nurse-assisted and self-administration), and hospitals (government and private).
  • Patient Age Groups: Analyzes adoption across adults, geriatrics, and pediatrics, highlighting unmet needs and tailored formulation approaches.
  • Regional Coverage: Segments the Americas (with detailed analysis for the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, and additional key countries), and Asia-Pacific (such as China, India, Japan, Australia, and others).
  • Company Developments: Reviews market moves from Sanofi SA, Regeneron Pharmaceuticals, Pfizer Inc., Johnson & Johnson, Novartis AG, AbbVie Inc., GlaxoSmithKline plc, Bayer AG, Leo Pharma A/S, and Merck & Co., Inc.

Key Takeaways for Senior Decision-Makers

  • Market growth is catalyzed by scientific breakthroughs such as monoclonal antibodies and new immunomodulators, rapidly changing clinical practice guidelines.
  • Sustained demand for safer alternatives to corticosteroids is driving companies to accelerate research and regulatory submissions for novel compounds.
  • Digital health tools, including teledermatology and real-time patient monitoring solutions, are making inroads in remote and urban markets, creating new access models.
  • Segmentation reveals specific preferences among age groups and care settings—pediatrics favor child-friendly formats, while geriatrics prioritize simplified dosing and minimal interactions.
  • Geographic variations require nuanced strategies: mature regions support advanced biologics through established reimbursement, whereas emerging markets focus on cost-effective generics and local partnerships.
  • Competitive positioning hinges on operational agility, brand trust, real-world evidence generation, and strong payer-provider alliances.

Tariff Impact and Supply Chain Considerations

The introduction of revised tariffs from 2025 has impacted cost structures, especially where reliance on imported active pharmaceutical ingredients is high. Companies are increasingly pursuing local sourcing and upstream integration to stabilize margins and ensure continuity. These changes have led to active pricing reviews, with downstream pressures evident in payer negotiations and formulary adjustments. Generics and over-the-counter segments have proven resilient, while biologics retain strategic pricing leverage under specialty coverage. A dual focus on supply chain agility and competitive pricing is essential in this shifting environment.

Methodology & Data Sources

Analysis is grounded in primary interviews with dermatologists, allergists, payers, and supply chain experts, bolstered by secondary research from peer-reviewed journals, regulatory filings, and financial disclosures. Quantitative data are subjected to triangulation and benchmarking, while qualitative findings draw on structured stakeholder dialogues. Rigor and data protection standards are maintained throughout all phases of research.

Why This Report Matters

  • Supports leadership teams in aligning commercial, clinical, and regulatory strategies to capitalize on shifting market conditions with actionable segmentation and regional insights.
  • Enables risk-mitigation planning, especially for organizations navigating tariff-driven disruptions and evolving supply chain models within the skin allergy therapeutics market.
  • Offers competitive advantage through deep dives on technology adoption, end-user preferences, and targeted product positioning.

Conclusion

The skin allergy therapeutics landscape is defined by scientific advancement, digital integration, and shifting payer frameworks. Informed decisions based on granular market intelligence will support long-term growth and sustained clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Skin Allergy Therapeutics Market, by Therapeutic Class
8.1. Introduction
8.2. Antihistamines
8.2.1. First Gen
8.2.2. Second Gen
8.3. Corticosteroids
8.3.1. High Potency
8.3.2. Low Potency
8.3.3. Medium Potency
8.4. Immune Response Modifiers
8.4.1. Calcineurin Inhibitors
8.4.2. PDE-4 Inhibitors
9. Skin Allergy Therapeutics Market, by Treatment Type
9.1. Introduction
9.2. Over the Counter
9.2.1. Systemic OTC
9.2.2. Topical OTC
9.3. Prescription
9.3.1. Systemic Rx
9.3.2. Topical Rx
10. Skin Allergy Therapeutics Market, by Application Type
10.1. Introduction
10.2. Creams & Ointments
10.2.1. Oil-In-Water
10.2.2. Water-In-Oil
10.3. Gels
10.4. Lotions
10.5. Sprays
11. Skin Allergy Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Online Pharmacies
11.3.1. Branded Platforms
11.3.2. Third Party Aggregators
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Skin Allergy Therapeutics Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Dermatology Clinics
12.2.2. General Clinics
12.3. Homecare
12.3.1. Nurse Assisted
12.3.2. Self Administration
12.4. Hospitals
12.4.1. Government Hospitals
12.4.2. Private Hospitals
13. Skin Allergy Therapeutics Market, by Patient Age Group
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Americas Skin Allergy Therapeutics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Skin Allergy Therapeutics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Skin Allergy Therapeutics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi SA
17.3.2. Regeneron Pharmaceuticals, Inc.
17.3.3. Pfizer Inc.
17.3.4. Johnson & Johnson
17.3.5. Novartis AG
17.3.6. AbbVie Inc.
17.3.7. GlaxoSmithKline plc
17.3.8. Bayer AG
17.3.9. Leo Pharma a/S
17.3.10. Merck & Co., Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SKIN ALLERGY THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. SKIN ALLERGY THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. SKIN ALLERGY THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SKIN ALLERGY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY FIRST GEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY SECOND GEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HIGH POTENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY LOW POTENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY MEDIUM POTENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PDE-4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY SYSTEMIC OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TOPICAL OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY SYSTEMIC RX, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TOPICAL RX, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OIL-IN-WATER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY WATER-IN-OIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY BRANDED PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THIRD PARTY AGGREGATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY NURSE ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 106. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 107. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 108. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 109. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 111. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 112. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 114. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 120. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 121. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 125. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 129. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 130. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 132. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 215. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 216. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 218. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 220. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 221. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 222. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 230. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 234. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 236. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 238. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 239. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 244. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 248. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 269. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 270. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 271. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 272. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 274. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 275. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 276. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 277. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 281. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 283. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 284. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 287. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 292. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 293. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 295. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 297. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 299. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 302. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 303. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNE RESPONSE MODIFIERS, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CREAMS & OINTMENTS, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Skin Allergy Therapeutics market report include:
  • Sanofi SA
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • Leo Pharma A/S
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.74 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Allergy Treatment Market by Treatment Type, Distribution Channel, Allergy Type, End User - Global Forecast to 2030 - Product Image

Allergy Treatment Market by Treatment Type, Distribution Channel, Allergy Type, End User - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Food Allergy Diagnostics & Therapeutics Market by Product Type, Allergen Type, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Food Allergy Diagnostics & Therapeutics Market by Product Type, Allergen Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Skin Allergy Therapeutics - Global Strategic Business Report - Product Image

Skin Allergy Therapeutics - Global Strategic Business Report

  • Report
  • 130 Pages
  • Global
From
Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Allergy Immunotherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.